Puig completes full takeover of dermocosmetics brand Isdin from Esteve

Puig signed an agreement with Corporación Químico-Farmacéutica Esteve to purchase the remaining share of Isdin, bringing its ownership to full 100%. The purchase price includes an upfront cash component at closing and a subsequent fixed deferred payment, funded through a combination of internal resources and borrowing. Completion is expected in the first quarter of 2027, with the deferred payment scheduled for a later date, subject to regulatory approval from competition authorities.

Until the transaction closes, Isdin will continue operating under its current governance structure. Puig frames the acquisition as a key step in consolidating its dermocosmetics portfolio, building on a partnership that began five decades ago.